01
Established Operating History
More than four decades of experience in diagnostic science, product development, manufacturing, and international markets.
Company Overview
Founded in 1977 by Dr. Rick Jerome, Monobind has grown from its early work in radioimmunoassay into an integrated diagnostic manufacturer with capabilities spanning immunoassay development, reagent production, laboratory instrumentation, biomaterials, quality systems, and global distribution.
The company remains privately held and focused on sustainable growth, scientific innovation, operational capability, and long-term value creation.
Investment Perspective
Monobind participates in complementary areas of the in vitro diagnostics industry, including clinical immunoassays, automated laboratory platforms, diagnostic raw materials, specialty matrices, OEM manufacturing, and international distribution.
This diversified capability base allows the company to support laboratories, distributors, researchers, and diagnostic manufacturers through multiple product and partnership models.
Company Strengths
Monobind combines scientific expertise, established manufacturing, international reach, and a broad portfolio of diagnostic technologies.
01
More than four decades of experience in diagnostic science, product development, manufacturing, and international markets.
02
In-house scientific, production, quality, biomaterial, automation, packaging, and commercial capabilities support greater control and responsiveness.
03
Products and services span clinical assays, instrumentation, diagnostic biomaterials, specialty matrices, OEM programs, and research applications.
04
An established international distributor and customer network supports participation across diverse geographic markets.
Business Platform
Monobind serves the diagnostic industry through complementary products, technologies, and commercial relationships.
Clinical Diagnostics
ELISA and chemiluminescence products supporting a broad range of clinical diagnostic applications.
View immunoassaysLaboratory Technology
Automated and semi-automated platforms designed to support laboratory workflow and testing efficiency.
View instrumentsDiagnostic Materials
Human serum, plasma, urine, fractions, and specialty matrices for diagnostic development and manufacturing.
View biomaterialsStrategic Programs
Private-label, co-brand, manufacturing, distribution, product development, and strategic collaboration opportunities.
Start a conversationStrategic Relationships
Monobind welcomes appropriate discussions with organizations and individuals whose experience, market access, technologies, or resources may complement the company’s long-term strategy.
Potential areas of alignment may include strategic investment, technology collaboration, product development, manufacturing, distribution, licensing, or other mutually beneficial relationships.
Scientific Leadership
Monobind was founded by Dr. Frederick “Rick” Jerome, who holds a PhD in Organic Chemistry and continues to serve as Founder and Chief Scientific Officer. His leadership has helped guide the company’s development across immunoassay science, reagent systems, diagnostic manufacturing, and biomaterials.
In 2024, Dr. Jerome received the Distinguished Alumnus Award from the USC Department of Chemistry in recognition of his outstanding contributions to the medical technology industry.
Company Information
Company Profile
Review our company, products, capabilities, markets, and global diagnostic presence.
Read the profileCompany History
Explore the scientific developments and milestones that have shaped Monobind since 1978.
View the timelineQuality & Compliance
Review our quality-system certification, regulatory registrations, product status, and manufacturing controls.
View certificationsInvestor Inquiries
Qualified parties interested in discussing potential investment or strategic opportunities may contact Monobind directly. Please include your name, organization, area of interest, and relevant background.
Important Notice
Monobind Inc. is a privately held company. Information on this page is provided for general informational purposes only and does not constitute an offer to sell, a solicitation of an offer to purchase, or investment, legal, tax, or financial advice. Any potential transaction would be subject to appropriate review, documentation, eligibility requirements, and applicable laws.